Day 2 of IPA's Pharmaceutical Quality Summit brought together global leaders and regulators across industries, emphasizing the importance of a…
New Delhi, July 24, 2021: In the complex environment where pharmaceuticals, nutraceuticals, AYUSH medicines, cosmeceuticals and herbal products and extracts, here…
Drug major Cipla NSE 0.65 % on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate…
Mumbai, November 11, 2020: The Indian pharma sector is expected to benefit from the Biden presidency on the back of…
Diabetic foot is one of the most significant and devastating complications of diabetes Out of approx. 70 million diabetics in India,…
Mumbai, June 01, 2019: In a cloud of an organised healthcare ecosystem, the demand for speciality chemicals and pharmaceutical products…
New Delhi, February 20, 2019: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) and Wellthy…
New Delhi, December 18, 2018: India Ratings and Research (Ind-Ra) believes that Cipla Limited’s (IND AAA/Stable) proposed acquisition of the…
Upon first stage closing, InvaGen Pharmaceuticals Inc., a Cipla subsidiary (“InvaGen”), to acquire shares representing a 33.3% stake in Avenue…
Mumbai, November 28, 2018: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its unaudited consolidated financial results for quarter ended September…